Navigation Links
Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share
Date:5/8/2008

extent required under applicable law.

Barr Pharmaceuticals, Inc. Selected Financial Data

(in millions, except per share amounts)

Three Months Three Months

Ended Ended

March 31, March 31,

2008 2007

Revenues:

Product sales $565 $560

Alliance and development revenue 32 25

Other revenue 11 12

Total revenues 608 597

Costs and expenses:

Cost of sales 275 300

Selling, general and administrative 194 179

Research and development 64 62

Write-off of acquired IPR&D - 2

Earnings from operations 75 54

Interest income 5 11

Interest expense 32 42

Other (expense) income (8) 1

Earnings before income taxes and

minority interest 40 24

Income tax expense 17 10

Minority interest - (1)

Net earnings from continuing

operations 23 13

Net loss from discontinued

operations, net of tax - (1)

Net earnings
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
2. Dendreon Reports First Quarter 2008 Financial Results
3. Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results
4. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
5. Oncothyreon Reports First Quarter 2008 Financial Results
6. iCAD Reports First Quarter 2008 Financial Results
7. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
8. American Oriental Bioengineering Reports First Quarter 2008 Financial Results
9. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
10. Onyx Pharmaceuticals Reports 2008 First Quarter Results
11. AtriCure Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
...5 The Environment Agency,-- Abu Dhabi (EAD) is te...ciences (ICLS), based in Washington DC, USA, to or...ference 2007: A Seminar for Life Science and,Polic...ember 12-14, 2007 at,the Hilton Hotel in Abu Dhabi...ne experts from around the world to discuss,enhanc...
... Friday, September 7, 2007, SAN DIEGO, Sept. 5 N...ced today that Neurocrine Biosciences will,present...ce. The live,presentation takes place Friday, Sept...0 a.m. Pacific Time (PT). The presentation will be... Company,s website at, http://www.neurocrine.com ...
... Forest Laboratories, Inc.,(NYSE: FRX ) and H. Lu...rt,of Appeals for the Federal Circuit has affirmed...rt for the District of Delaware which determined t...ive ingredient in Lexapro(R),is valid and upheld t...ric,product launch, thereby confirming Forest,s an...
Other Biology Technology:Biosafety and Biosecurity International Conference 2007 to be held in Abu Dhabi from November 12 to 14 2Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision 2
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
(Date:12/2/2009)PHILADELPHIA Cigarette smoking and alcohol consumption before head and neck cancer diagnosis strongly predicts the patient,s future risk of death, according to published studies. Now, results of a ne
(Date:12/2/2009)WEST LAFAYETTE, Ind. ╤ A Smoky Mountain forest,s woodland herb population has shown that climate may play a role in how forest understories recover from logging, according to Purdue University r
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Study finds logging effects vary based on a forest's history, climate 2DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 1DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 2DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 3DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 4Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni body Internal Skeleton 54719 1Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni body Internal Skeleton 54719 2Aethlon Medical to Present at Todays Southern California Investor Conference 54714 1Aethlon Medical to Present at Todays Southern California Investor Conference 54714 2
...Minnesota researchers has discovered how a gene th...r human cancers works. The study points the way to... researchers, led by Zigang Dong, director of the ...ve applied for a patent on one such treatment. The...nal Nature Structural & Molecular Biology. , A...
...r viral-based therapies for cancer , Researchers ...make strides in their work to develop the next gen...cer. Two papers about promising research with gen...shed today in the journals Cancer Research and the...PNAS), bring us significantly closer to this objec...
...nal Institute of Mental Health (NIMH), part of the...genetically controlled brain mechanism responsible...portant but least understood aspects of human natu...ce, published online on July 10, 2005. , The study...e with a genetic abnormality, Williams Syndrome, a...
Other Biology News:Columbia scientists develop cancer terminator viruses 2Columbia scientists develop cancer terminator viruses 3Scientists uncover new clues about brain function in human behavior 2Scientists uncover new clues about brain function in human behavior 3
LEVAMISOLE SOLUTION from Invitrogen
Rabbit Anti-Human UCP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Catch and Release® v2.0
Reversible Immunoprecipitation System from Upstate
DTNB from Cayman Chemical
Biology Products: